Weekly Updates 10/7/23 – 14/7/23 July 10, 2023

Weekly Updates 10/7/23 – 14/7/23

Weekly Updates 10/7/23 – 14/7/23

This weekly update is designed to help you stay informed and relate economic and company earnings to potentially value-add your CFD (Contract For Difference) trading via hedging (risk reducing). This article should be used for educational purposes only and not as financial advice. We urge all traders to carry out your own due diligence before submitting trades.

Recap for last week (03 July 2023 – 07 July 2023)

Weekly Updates 10/7/23 – 14/7/23*These prices are taken based on the previous Monday’s opening price and the preceding Friday’s closing price.

Last week’s market action revolved around US Federal Reserve minutes revealing that a large majority of Fed officials expect rates to remain high longer. Sending most indexes to close lower. WIth Nikkei 225 and Hang Seng Index closing -3+% lower. Hang Seng tech rose ~2% due to market participants expecting the China regulatory body to conclude the regulatory crackdown on China Finance technology companies like Ant Financial. Stronger than expected data coming out of the US, pointing at a possible longer than expected high rates environment from the Fed.

Updates for the week (10 July 2023 – 14 July 2023)

The data below showing the economic releases read as “Analyst’s estimate/ Consensus | Previous data”.

Weekly Updates 10/7/23 – 14/7/23

This week’s macro news mainly focuses on the sentiment data from the US, production data from SG while China is releasing its inflation and trade data. The US economy is pricing in the higher interest rates environment along with the hawkish comments by the FED, thus some investors are expecting a lower CPI reading. Although there are conflicting expectations with PPI Final demand increasing and the Sentiment improving, many investors are still on the sideline. Analysts are expecting China PPI deflation steepens since demand for China’s products worsen. This is supported by the expectations of falling China Exports where it signals to the market participants that the recovery of China weakens.

Weekly Updates 10/7/23 – 14/7/23

This week’s corporate earnings releases are mainly from the US. Some of the big banks like JP, Black Rock and Citi Group are the first to release their earnings which gives a heads up to investors of how the bank sector is doing in an increasing interest rate environment. On the other hand, market participants who has exposure in healthcare sector are paying attention to United Health earning release as the results give a forward guidance about the insurers in the industry, whether are they paying more claims than collecting premiums. This also give them a glimpse of the hospitals whereby are they profiting more from the insurers since medical costs are on the rise.

If you hold equity positions in these stocks, you can hedge your positions using CFDs to mitigate the risk of disappointing earnings releases.

For those looking to speculate or capitalize on the increased volatility, CFDs provide leverage and ease of going long and short across a broad range of products available.

Weekly Updates 10/7/23 – 14/7/23

SIA (C6L) Trading Opportunity – by Alex

Weekly Updates 10/7/23 – 14/7/23

Trade Set-up:

  • Looking at the daily chart of SIA, we can see that price has hit the resistance line (red line) of $7.73 and failed to close above it, rejecting the resistance line.
  • Currently, price has formed a downward trend channel.

Trade Execution:

  • We can look for shorts upon rejection of the resistance of the downward channel based on a shorter timeframe in confluence with the daily timeframe bias. We may see price extending towards the support of the trend channel.
  • However, a break above the resistance of the downwards channel may signal an overall shift to the upside and we may look for longs upon retracement.

Weekly Updates 10/7/23 – 14/7/23

AUD/USD kicks off the week on the front foot as China’s inflation eyed

Weekly Updates 10/7/23 – 14/7/23

Trade Set-up:

  • AUD/USD opens the week on a positive momentum where last week’s attempt to break below the 0.66 handle was quelled with a swift rebound on Thursday and Friday, with a disappointing US NFP amid productive US-Sino talks. All eyes remain on the US CPI data, RBA Governor Lowe’s speech, and China inflation numbers.
  • From a technical perspective, the pair traded into a mini consolidation phase between the 0.6600 to 0.6720 levels. It may appear the pair is attempting a double bottom having tested the 0.6600 levels twice but needs better price breakthroughs to confirm this. RSI indicator is sitting on the fence as well.

Trade Execution:

  • Technically, the pair is considered on range trading. Investors looking to trade should trade on the range, else, to stay put until a breakthrough in price movements is sought.
  • Traders could use these levels as technical guides to either limit their losses or take on new positions with breakout plays to either side.

If you have any feedback or questions, feel free to email us at samht@phillip.com.sg or onishathyeyn@phillip.com.sg or cfd@phillip.com.sg.


This material is provided to you for general information only and does not constitute a recommendation, an offer or solicitation to buy or sell the investment product mentioned. It does not have any regard to your specific investment objectives, financial situation or any of your particular needs.

Accordingly, no warranty whatsoever is given and not liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of your acting based on this information. Investments are subject to investment risks.

The risk of loss in leveraged trading can be substantial. You may sustain losses in excess of your initial funds and may be called upon to deposit additional margin funds at short notice. If the required funds are not provided within the prescribed time, your positions may be liquidated.

The resulting deficits in your account are subject to penalty charges. The value of investments denominated in foreign currencies may diminish or increase due to changes in the rates of exchange.

You should also be aware of the commissions and finance costs involved in trading leveraged products. This product may not be suitable for clients whose investment objective is preservation of capital and/or whose risk tolerance is low.

Clients are advised to understand the nature and risks involved in margin trading. You may wish to obtain advice from a qualified financial adviser, pursuant to a separate engagement, before making a commitment to purchase any of the investment products mentioned herein. In the event that you choose not to obtain advice from a qualifies financial adviser, you should assess and consider whether the investment product is suitable for you before proceeding to invest and we do not offer any advice in this regard unless mandated to do so by way of a separate engagement.

You are advised to read the trading account Terms & Conditions and Risk Disclosure Statement (available online at www.poems.com.sg) before trading in this product. Any CFD offered is not approved or endorsed by the issuer or originator of the underlying securities and the issuer or originator is not privy to the CFD contract. This advertisement has not been reviewed by the Monetary Authority of Singapore.

About the author

Sam Hei Tung, Dealing and Onisha Thye, Dealing

Sam graduated from National University of Singapore with a Master of Science in Finance. He personally manages his own investment portfolio and does equity and economic research in his free time. Sam believes that education and information is essential to making good financial decisions.

Onisha is a dealer at the CFD Dealing Desk. She graduated from Monash University with a double major in finance and econometrics. Her natural curiosity for finance is what drove her to be in this field as she is fascinated by all the possibilities and opportunities that are available to grow one’s wealth, either through trading or investment.

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you


This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  


Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com